Literature DB >> 10685932

Concentrations of antimony in infants dying from SIDS and infants dying from other causes.

A Cullen1, B Kiberd, D Devaney, J Gillan, P Kelehan, T G Matthews, P Mayne, N Murphy, M O'Regan, W Shannon, L Thornton.   

Abstract

OBJECTIVES: Raised concentrations of antimony have been found in infants dying of sudden infant death syndrome (SIDS). The presumed source of this antimony is toxic gases generated from fire retardants that are present in cot mattresses. The aim of this study was to determine the role of antimony in SIDS.
DESIGN: Samples of liver, brain, serum, and urine were collected from all patients dying from SIDS and a group of aged matched control infants who had died of other causes.
SETTING: Nationwide study in Ireland.
SUBJECTS: 52 infants dying from SIDS and 19 control infants aged > 7 days and < 1 year.
RESULTS: The median concentration of antimony in the liver and brain of infants dying of SIDS was < 1 ng/g, with no difference detected between the infants dying from SIDS and the control infants. The range of antimony in the serum of infants dying of SIDS was 0.09-0.71 microg/litre (median, 0.26). Although no difference was found between infants dying from SIDS and control infants, SIDS infants were found to have higher concentrations when compared with healthy infants in the 1st year of life, probably as a result of release of antimony into serum after death. Urine antimony concentrations in infants dying from SIDS were < 3.91 ng/mg (corrected for creatinine) and similar to values found both in control infants and healthy infants.
CONCLUSION: There is no evidence to support a causal role for antimony in SIDS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10685932      PMCID: PMC1718263          DOI: 10.1136/adc.82.3.244

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  17 in total

1.  Cot mattress biodeterioration and SIDS.

Authors:  B A Richardson
Journal:  Lancet       Date:  1990-03-17       Impact factor: 79.321

2.  Pharmacokinetics of antimony during treatment of visceral leishmaniasis with sodium stibogluconate or meglumine antimoniate.

Authors:  J D Chulay; L Fleckenstein; D H Smith
Journal:  Trans R Soc Trop Med Hyg       Date:  1988       Impact factor: 2.184

3.  [Activation analysis measurements of an non-homogeneous partially parallel running distribution of cobalt, iron, selenium, zinc and antimony in various areas of the liver, lung, kidney, heart and aorta].

Authors:  H Schicha; K Kasperek; L E Feinendegen; V Siller; H J Klein
Journal:  Beitr Pathol       Date:  1972-04

4.  Fire retardants, biocides, plasticisers, and sudden infant deaths.

Authors:  P J Fleming; M Cooke; S M Chantler; J Golding
Journal:  BMJ       Date:  1994-12-17

5.  Analysis of diseased and normal lung tissue for trace antimony content by neutron activation analysis.

Authors:  J H Kennedy
Journal:  Am J Med Sci       Date:  1966-01       Impact factor: 2.378

6.  Toxicity of antimony and its compounds.

Authors:  K A Winship
Journal:  Adverse Drug React Acute Poisoning Rev       Date:  1987

7.  Distribution of trace elements in the human body determined by neutron activation analysis.

Authors:  M Yukawa; K Amano; M Suzuki-Yasumoto; M Terai
Journal:  Arch Environ Health       Date:  1980 Jan-Feb

8.  Antimony in blood and urine of infants.

Authors:  A Cullen; B Kiberd; T Matthews; P Mayne; H T Delves; M O'Regan
Journal:  J Clin Pathol       Date:  1998-03       Impact factor: 3.411

9.  Heavy metals in normal Japanese tissues. Amounts of 15 heavy metals in 30 subjects.

Authors:  K Sumino; K Hayakawa; T Shibata; S Kitamura
Journal:  Arch Environ Health       Date:  1975-10

10.  Sudden infant death syndrome: a possible primary cause.

Authors:  B A Richardson
Journal:  J Forensic Sci Soc       Date:  1994 Jul-Sep
View more
  1 in total

Review 1.  Antimony toxicity.

Authors:  Shyam Sundar; Jaya Chakravarty
Journal:  Int J Environ Res Public Health       Date:  2010-12-20       Impact factor: 3.390

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.